Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 293

1.

The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.

Johannes CB, Koro CE, Quinn SG, Cutone JA, Seeger JD.

Pharmacoepidemiol Drug Saf. 2007 May;16(5):504-12.

PMID:
17245800
[PubMed - indexed for MEDLINE]
2.

The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.

Ziyadeh N, McAfee AT, Koro C, Landon J, Arnold Chan K.

Clin Ther. 2009 Nov;31(11):2665-77. doi: 10.1016/j.clinthera.2009.11.003.

PMID:
20110009
[PubMed - indexed for MEDLINE]
3.

Coronary heart disease outcomes in patients receiving antidiabetic agents.

McAfee AT, Koro C, Landon J, Ziyadeh N, Walker AM.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):711-25.

PMID:
17551989
[PubMed - indexed for MEDLINE]
4.

Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.

Azoulay L, Schneider-Lindner V, Dell'aniello S, Schiffrin A, Suissa S.

Pharmacoepidemiol Drug Saf. 2010 Apr;19(4):335-42. doi: 10.1002/pds.1834.

PMID:
20052677
[PubMed - indexed for MEDLINE]
5.

Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.

Aquilante CL, Zhang W, McCollum M.

Curr Med Res Opin. 2007 Mar;23(3):489-94.

PMID:
17355730
[PubMed - indexed for MEDLINE]
6.

Evaluation of adverse events of oral antihyperglycemic monotherapy experienced by a geriatric population in a real-world setting: a retrospective cohort analysis.

Asche CV, McAdam-Marx C, Shane-McWhorter L, Sheng X, Plauschinat CA.

Drugs Aging. 2008;25(7):611-22.

PMID:
18582148
[PubMed - indexed for MEDLINE]
7.

Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.

Hsiao FY, Huang WF, Wen YW, Chen PF, Kuo KN, Tsai YW.

Drug Saf. 2009;32(8):675-90. doi: 10.2165/00002018-200932080-00006.

PMID:
19591532
[PubMed - indexed for MEDLINE]
8.

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

Diabetes Care. 2006 Feb;29(2):254-8.

PMID:
16443869
[PubMed - indexed for MEDLINE]
9.

Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.

Riedel AA, Heien H, Wogen J, Plauschinat CA.

Am J Manag Care. 2007 Aug;13(8):457-63.

PMID:
17685826
[PubMed - indexed for MEDLINE]
Free Article
10.

Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.

Walker AM, Koro CE, Landon J.

Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):760-8. doi: 10.1002/pds.1598.

PMID:
18383443
[PubMed - indexed for MEDLINE]
11.

Economic effect of augmentation strategies in patients with type 2 diabetes initiated on sulfonylureas.

Kalsekar I, Latran M.

Manag Care Interface. 2007 Sep;20(9):39-46.

PMID:
18161391
[PubMed - indexed for MEDLINE]
12.

Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

Riedel AA, Heien H, Wogen J, Plauschinat CA.

Pharmacotherapy. 2007 Aug;27(8):1102-10.

PMID:
17655510
[PubMed - indexed for MEDLINE]
13.

Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database.

Rascati K, Richards K, Lopez D, Cheng LI, Wilson J.

Diabetes Obes Metab. 2013 Oct;15(10):901-5. doi: 10.1111/dom.12103. Epub 2013 Apr 18.

PMID:
23531154
[PubMed - indexed for MEDLINE]
14.

Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.

Rascati KL, Richards KM, Lopez D, Cheng LI, Wilson JP.

Clin Ther. 2011 Dec;33(12):2016-20. doi: 10.1016/j.clinthera.2011.10.018. Epub 2011 Nov 21.

PMID:
22101160
[PubMed - indexed for MEDLINE]
15.

Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.

Inzucchi SE, Masoudi FA, Wang Y, Kosiborod M, Foody JM, Setaro JF, Havranek EP, Krumholz HM.

Diabetes Care. 2005 Jul;28(7):1680-9.

PMID:
15983320
[PubMed - indexed for MEDLINE]
16.

Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.

Alvarez Guisasola F, Mavros P, Nocea G, Alemao E, Alexander CM, Yin D.

Diabetes Obes Metab. 2008 Jun;10 Suppl 1:8-15. doi: 10.1111/j.1463-1326.2008.00881.x.

PMID:
18435669
[PubMed - indexed for MEDLINE]
17.

Thiazolidinedione addition reduces the serum retinol-binding protein 4 in type 2 diabetic patients treated with metformin and sulfonylurea.

Lin KD, Chang YH, Wang CL, Yang YH, Hsiao PJ, Li TH, Shin SJ.

Transl Res. 2008 Jun;151(6):309-14. doi: 10.1016/j.trsl.2008.04.003. Epub 2008 May 16.

PMID:
18514142
[PubMed - indexed for MEDLINE]
18.

Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration.

Kahler KH, Rajan M, Rhoads GG, Safford MM, Demissie K, Lu SE, Pogach LM.

Diabetes Care. 2007 Jul;30(7):1689-93. Epub 2007 Apr 17.

PMID:
17440170
[PubMed - indexed for MEDLINE]
19.

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

Jermendy G; Hungarian RECAP Group, Erdesz D, Nagy L, Yin D, Phatak H, Karve S, Engel S, Balkrishnan R.

Health Qual Life Outcomes. 2008 Oct 31;6:88. doi: 10.1186/1477-7525-6-88.

PMID:
18976457
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications.

Stockl KM, Le L, Zhang S, Harada AS.

Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):166-74. doi: 10.1002/pds.1700.

PMID:
19109802
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk